RESUMEN
OBJECTIVE: Understanding the effects of benzodiazepines (BZDs) on maternal/fetal health remains incomplete despite their frequent use. This article quantifies the effects of antenatal BZD exposure on delivery outcomes. DATA SOURCES: Medline, PsycINFO, CINAHL, Embase, and the Cochrane Library were searched till June 30, 2018. STUDY SELECTION: English-language cohort studies comparing antenatal BZD exposure to an unexposed group on any delivery outcome were eligible. In all, 23,909 records were screened, 56 studies were assessed, and 14 studies were included. DATA EXTRACTION: Two reviewers independently assessed quality and extracted data. Estimates were pooled using random effects meta-analysis. Sub-analyses examined several potential moderators including timing of exposure. RESULTS: There were 9 outcomes with sufficient data for meta-analysis. Antenatal BZD exposure was significantly associated with increased risk of 6 outcomes initially: spontaneous abortion (pooled odds ratio = 1.86; 95% confidence interval [CI], 1.43 to 2.42), preterm birth (1.96; 95% CI, 1.25 to 3.08), low birth weight (2.24; 95% CI, 1.41 to 3.88), low Apgar score (2.19; 95% CI, 1.94 to 2.47), Neonatal Intensive Care Unit (NICU) admission (2.61; 95% CI, 1.64 to 4.14), and induced abortion (2.04; 95% CI, 1.23 to 3.40). There was significant heterogeneity between studies for most outcomes without consistent moderators. Birth weight (mean difference [MD]: -151.35 g; 95% CI, -329.73 to 27.03), gestational age (-0.49 weeks; 95% CI, -1.18 to 0.19), and small for gestational age (SGA; 1.42; 95% CI, 1.00 to 2.01) did not show significant associations although after adjusting for publication bias, gestational age, and SGA became significant, totaling 8 significant outcomes. CONCLUSIONS: Antenatal BZD exposure appears to be statistically associated with increased risk of several adverse perinatal outcomes. Although confounds cannot be ruled out, NICU admission does appear clinically relevant and consistent with the antidepressant literature.
Asunto(s)
Antidepresivos/efectos adversos , Benzodiazepinas/efectos adversos , Complicaciones del Embarazo/psicología , Resultado del Embarazo , Nacimiento Prematuro , Adulto , Femenino , Humanos , Recién Nacido , Exposición Materna/efectos adversos , Exposición Materna/estadística & datos numéricos , Embarazo , Complicaciones del Embarazo/tratamiento farmacológico , Nacimiento Prematuro/inducido químicamente , Efectos Tardíos de la Exposición Prenatal/inducido químicamenteRESUMEN
Intimate partner violence (IPV) is common worldwide and occurs in more than one-third of American women and psychiatric patients. As well as physical injuries, it may cause mental health sequelae, such as depression, anxiety, posttraumatic stress disorder, psychosis, inability to trust others, self-harm, and a host of psychosomatic conditions, that may be referred to psychiatrists. It is imperative that psychiatrists know the risk factors, how to assist disclosure of IPV, and how to safely respond. Psychiatrists must know the best evidence-based management of IPV and its mental health sequelae to best assist patients who have been exposed to IPV.
Asunto(s)
Violencia de Pareja/psicología , Violencia de Pareja/estadística & datos numéricos , Trastornos Mentales/epidemiología , Trastornos Mentales/psicología , Salud Mental , Adulto , Depresión/epidemiología , Depresión/psicología , Femenino , Humanos , Prevalencia , Trastornos Relacionados con Sustancias/epidemiología , Trastornos Relacionados con Sustancias/psicologíaRESUMEN
OBJECTIVE: The study evaluated the association between physician follow-up within 30 days after hospital discharge and psychiatric readmission within the subsequent 180 days. METHODS: Among inpatients with schizophrenia who were discharged between 2007 and 2012 in Ontario (N=19,132), those who had a 30-day follow-up visit with a primary care physician (PCP) only, a psychiatrist only, or both were compared with a no-follow-up group. The primary outcome was psychiatric readmission in the subsequent 180 days. Secondary analyses stratified the sample on the basis of readmission risk at discharge. RESULTS: About 65% of patients had follow-up care within 30 days postdischarge. Psychiatric readmission rates were similar among patients with any physician follow-up and significantly lower than among those with no follow-up (26%): PCP only: 22%; adjusted hazard ratio [aHR]=.88, 95% confidence interval [CI]=.81-.96; psychiatrist only, 22%; aHR=.84, CI=.77-.90; both, 21%, aHR=.82, CI=.75-.90). In stratified analyses, 66% of patients were in the category at highest risk of psychiatric readmission, and the effect of follow-up with any physician was significant for these patients, compared with high-readmission risk patients with no follow-up, who had a 29% readmission rate (PCP only, 20% readmission rate, aHR=.85, CI=.77-.94; psychiatrist only, 29%, aHR=.84, CI=.77-.92; both, 17%, aHR=.81, CI=.73-.90). DISCUSSION: Timely physician follow-up was associated with reduced risk of psychiatric readmissions, with the greatest reduction among patients at high risk of readmission. Because more than one-third of patients had no physician visit within 30 days postdischarge, improving physician follow-up may help reduce psychiatric readmission rates.
Asunto(s)
Cuidados Posteriores/estadística & datos numéricos , Hospitales Psiquiátricos/estadística & datos numéricos , Readmisión del Paciente/estadística & datos numéricos , Médicos/estadística & datos numéricos , Esquizofrenia/terapia , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Ontario/epidemiología , Alta del Paciente/estadística & datos numéricos , Médicos de Atención Primaria/estadística & datos numéricos , Psiquiatría/estadística & datos numéricos , Esquizofrenia/epidemiología , Adulto JovenRESUMEN
Intimate partner violence (IPV) is common worldwide and occurs in more than one-third of American women and psychiatric patients. As well as physical injuries, it may cause mental health sequelae, such as depression, anxiety, posttraumatic stress disorder, psychosis, inability to trust others, self-harm, and a host of psychosomatic conditions, that may be referred to psychiatrists. It is imperative that psychiatrists know the risk factors, how to assist disclosure of IPV, and how to safely respond. Psychiatrists must know the best evidence-based management of IPV and its mental health sequelae to best assist patients who have been exposed to IPV.
Asunto(s)
Violencia de Pareja/psicología , Violencia de Pareja/estadística & datos numéricos , Trastornos Mentales/epidemiología , Revelación , Humanos , Trastornos Mentales/prevención & control , Trastornos Mentales/terapia , Factores de RiesgoRESUMEN
OBJECTIVE: The objective of this study was to identify differences between men and women hospitalized for psychiatric conditions. METHODS: Men and women with an inpatient psychiatric hospitalization in Ontario, Canada, between 2008 and 2013 (N=95,055) were compared on sociodemographic characteristics, health history, and clinical profiles and on 30-day and 90-day postdischarge readmission, emergency department (ED) visits, self-harm, and death. RESULTS: Compared with men, women were older and more likely to be educated, to live with a partner, and to report trauma history. Mood disorders were more common among women; psychotic and substance use disorders were more common among men. Postdischarge, there was no difference in either readmission or ED revisits. Compared with men, women had greater risk of self-harm at 30 days (adjusted odds ratio [AOR]=1.17, 95% confidence interval [CI]=1.04-1.32) and at 90 days (AOR=1.28, CI=1.17-1.39). Death was rare (<1%), with women at lower risk at both 30 days (AOR=.49, CI=.38-.63) and 90 days (AOR=.53, CI=.45-.63). CONCLUSIONS: These data can inform inpatient psychiatric service delivery for both men and women.